News

Weight-Loss Drug Semaglutide Shows Promise In Reversing Liver Disease, Study Finds

Kristen Butler

Published

on

Michael Siluk / UCG / Universal Images Group / Newscom / The Mega Agency

A popular diabetes and weight loss medication may offer new hope to patients suffering from liver disease.

According to a new study published in the New England Journal of Medicine, semaglutide — already widely prescribed under brand names like Wegovy and Ozempic — appears to significantly improve liver health in individuals with metabolic dysfunction-associated steatohepatitis (MASH), a progressive and potentially serious liver condition.

MASH, which involves fat buildup, chronic inflammation, and scarring of the liver, has long posed a treatment challenge. However, the new multicenter, randomized, double-blind, placebo-controlled trial, sponsored by drugmaker Novo Nordisk, suggests that semaglutide may be able to reverse some of the diseases damaging effects.

The study enrolled 1,197 patients diagnosed via biopsy with MASH and fibrosis stage 2 or 3. Participants received either a placebo or 2.4 mg of semaglutide administered weekly for a planned total of 240 weeks. Preliminary results reported after 72 weeks, involving data from the first 800 patients, have drawn attention from the medical community.

According to obesity medicine expert Dr. Dyan Hes, a Diplomate of the American Board of Obesity Medicine (ABOM) who was not involved in the trial, the early outcomes are “extremely promising.”

“Steatohepatitis resolved, without worsening of fibrosis, in 62.9% of the 534 patients in the semaglutide group,” said Hes, Medical Director at Highline Modern Medicine. “A reduction in liver fibrosis without worsening of steatohepatitis was reported in 36.8% of the semaglutide group.”

While researchers are still unclear on how semaglutide reduced liver scarring, the drug’s impact is notable. Patients treated with semaglutide also lost an average of 10.5% of their body weight — a significant reduction that likely played a role in improving liver health.

“This study shows that there will be a lot more beneficial health outcomes from the ripple effect of semaglutide and other GLP-1 agonists,” Hes said. “So far we know that they help treat diabetes, cardiovascular disease, renal disease, and there are studies now to see if they help prevent or improve Alzheimers disease.”

While additional research will be needed to confirm long-term results, the findings provide new optimism for those with MASH, for whom few effective treatments currently exist.

Semaglutides expanding therapeutic potential is being closely watched, particularly given the rising prevalence of obesity-related conditions in the U.S. and globally.

Trending News

REAL ESTATE1 week ago

JD Vance’s Temporary Florida Home Owned by President Trump Hits Rental Market for $110K a Month

Donald Trump and Nicki Minaj Donald Trump and Nicki Minaj
Politics2 weeks ago

President Trump Doesn’t Know Nicki Minaj Isn’t a US Citizen Amid New Press Secretary Speculation

News2 weeks ago

Young Pilot’s Harrowing Last Words Revealed Before Florida Plane Crash That Killed All on Board

Celebrity News1 week ago

Kid Rock Hit With Backlash After Positing Hunting Photo With Dead Elk: ‘How Sick Is This’

Exclusive1 week ago

Meghan Markle’s Dad Thomas Once Bragged About ‘Incredible’ Things He Paid Women to Do to Him Prior to Arrest

Crime2 weeks ago

Mother Receives 7 Consecutive Life Sentences for Allowing Husband to Impregnate Her Daughter

RELATIONSHIPS6 days ago

Ainsley Earhardt Admits New Husband Sean Hannity ‘Won’t Let’ Her Get the Cosmetic Procedure She Wants

Stephen Baldwin, Chynna Phillips, Bijou Phillips, Mackenzie Phillips, Billy Baldwin Stephen Baldwin, Chynna Phillips, Bijou Phillips, Mackenzie Phillips, Billy Baldwin
Celebrity2 weeks ago

Mackenzie, Chynna and Bijou Phillips Enjoy Mini-Reunion at Event Years After Family Turmoil

Politics7 days ago

Franklin Graham Warns ‘Religion Can’t Save You’ After President Donald Trump’s ‘60 Minutes’ Interview

Don Jr. and Russell Brand Don Jr. and Russell Brand
Legal News4 days ago

Donald Trump Jr. Defends Russell Brand Following Prison Sentencing: ‘No One Had a Problem With It’

Politics2 weeks ago

Elderly New Hampshire Man Slapped Turning Point Activist During Polling Station Showdown

Crime2 weeks ago

Suspiciously Large Costco Order From School Cook Leads to Discovery of $300K Embezzlement Schemes